Tarsons Products Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 7,702,929 (50%) | — | ₹50,993 Cr |
| NII (HNI) | — | 2,310,880 (15%) | — | ₹15,298 Cr |
| Retail | — | 5,392,052 (35%) | — | ₹35,695 Cr |
| Employee | — | 60,000 (0%) | — | ₹40 Cr |
| Σ Total | — | 15,465,861 (100%) | — | ₹1,023,840 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 22 | ₹14,564 |
| Retail (Max) | 13 | 286 | ₹189,332 |
| S-HNI (Min) | 14 | 308 | ₹203,896 |
| B-HNI (Min) | 67 | 1,474 | ₹975,788 |
Financial Statements Amount in Crore
| Metric | 30-Jun-21 | 31-Mar-21 |
|---|---|---|
| Revenue | 71 | 234 |
| Profit After Tax | 25 | 69 |
| Total Assets | 365 | 296 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Repayment/prepayment of certain borrowings of our Company – 78.54
- 2 Funding capital expenditure for the Proposed Expansion – 62.00
- 3 General corporate purposes – 1.62
Company Overview
Tarsons Products Limited is a leading Indian life sciences company with more than three decades of experience in the production and supply of labware products. The company manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare systems. The company's product portfolio is classified into three broad categories including consumables, reusables, and others. As of March 31, 2021, the company has a diversified product portfolio with over 1,700 SKUs across 300 products.
Trason's products are used in various laboratories across research organizations, academic institutes, pharmaceutical companies, Contract Research Organizations (CRO), diagnostic companies, and hospitals. The company has many reputed institutes, medical labs, and hospitals as its key clients.
Currently, the company has 5 manufacturing facilities located in West Bengal spread across approximately 20,000 sq. mts of area. The company has a strong distribution network across India comprising of over 141 authorized distributors as of March 31, 2021 and supplies its products to more than 40 countries.
Competitive Strengths:
- Leading supplier of life sciences products
- Extensive product offering
- Large addressable market of life sciences industry
- Well-equipped and automated manufacturing facilities
- Strong sales and distribution network
- Experienced Promoter backed by a strong management team